| Table of Contents |
|
| Preface |
|
|
0 |
| Acknowledgements |
|
|
0 |
| Chapter 1 Dengue: overview and epidemiology |
|
|
1 |
| Dengue: an overview |
|
| T Tantawichien, U Thisyakorn |
2 |
| A short history of dengue and Mahidol dengue vaccine |
|
| S Yoksan |
20 |
| Prospective study of dengue in Bangkok during 2015-2016 |
|
| W Liulak, P Saichaer, W Waidab, A Pungjitprapai, S Buranakitsin, B Suntorn-opas, S Utensute, A Lekhakul, N Kittikool, E Wanitcharoenkul, T Laohasurayotin, P Potidang, W Wonglak, M Chatameteekul, U Thisyakorn |
33 |
| Epidemiology of dengue at Thammasat University Hospital during 2006-2015 |
|
| A Tangsathapornpong, C Puriburt, P Bunjoungmanee |
39 |
| Changing epidemiology of dengue patients at Vachira Phuket Hospital, Thailand |
|
| W Lawtongkum, U Thisyakorn, C Thisyakorn |
47 |
| Chapter 2 Dengue pathogenesis |
|
|
52 |
| Pathogenesis of dengue viral diseases |
|
| N Sittisombut |
53 |
| Hematologic changes in dengue |
|
| D Sosothikul, U Thisyakorn, C Thisyakorn |
60 |
| Cytokine-related gene expression in peripheral blood leukocytes and dengue infection severity |
|
| O Prommalikit, W Waidab, K Suphapeetiporn, U Thisyakorn |
62 |
| Chapter 3 Diagnosis of dengue virus infection |
|
|
67 |
| WHO 2009 guidelines and case classification: an update and short report |
|
| O Horstick, S Runge-Ranzinger |
68 |
| Comparison of the 1997 and 2009 WHO classifications for determining dengue severity in Thai patients |
|
| A Tangsathapornpong, P Bunjoungmanee, P Pengpris, T Khawcharoenporn |
75 |
| Laboratory diagnosis of dengue virus infections |
|
| A Nisalak |
83 |
| Chapter 4 Clinical features and management of dengue patients |
|
|
105 |
| Childhood dengue diseases: a twenty years prospective study |
|
| U Thisyakorn, C Thisyakorn |
106 |
| Dengue: pitfalls in diagnosis and management |
|
| U Thisyakorn, C Thisyakorn |
112 |
| Role of tourniquet test in dengue patients |
|
| N Srisawat, K Pongpirul, T Choonchuachan, S Peerapornratana, N Lumlertgul, A Lauruengthana, R Phahonthep, T Tantawichien, U Thisyakorn |
117 |
| Manifestations of dengue in age groups of Thai children and adults: a cross sectional study |
|
| A Tiawilai, T Tiawilai, U Thisyakorn |
122 |
| Risk factors for severe dengue |
|
| K Laoprasopwattana, A Geater |
128 |
| Dengue in pregnancy |
|
| S Chaithongwongwatthana |
134 |
| Maternal and fetal outcomes of dengue infection during pregnancy |
|
| A Tiawilai, S Trongkamolchai, K Khamim, U Thisyakorn |
139 |
| Dengue and the cardiovascular system |
|
| C Thisyakorn, U Thisyakorn |
143 |
| Current management of liver complications in adult dengue infection |
|
| S Treeprasertsuk, P Wilairatana |
152 |
| Renal dysfunction in dengue virus infection |
|
| P Puapatanakul, N Lumlertgul, N Srisawat |
160 |
| Critical care in dengue management |
|
| N Srisawat, N Lumlertgul, P Laoveerawat, S Peerapornratana |
171 |
| Chapter 5 Dengue prevention and control |
|
|
180 |
| Dengue vector control: assessing what works? |
|
| O Horstick, R Boyce, S Runge-Ranzinger |
181 |
| Prospects for the development of a dengue vaccine |
|
| U Thisyakorn, C Thisyakorn |
196 |
| The estimated impact and cost-effectiveness of dengue vaccination |
|
| P Rattanaumpawan |
202 |
| Chapter 6 Adult dengue cases |
|
|
206 |
| Hemophagocytic lymphohistiocytosis and acute kidney injury with severe nephrotic syndrome in dengue patients: a case report |
|
| P Puapatanakul, N Srisawat |
207 |
| Annex I 1st Asian dengue summit (ADS): Are we ready for the new vaccine era? |
|
| R Velayudhan, I-K Yoon, DJ Gubler, TJ Hladish, CAB Pearson, IM Longini, J Hombach, SN Buang, R Jahis, LL Suy, W Liulak, IN Kandun |
212 |
| Annex II Name list of participants |
|
|
225 |
